Bausch + Lomb acquires Blink eye drops
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
The strategic acquisition demonstrates the company’s commitment to increasing OTC consumer convenience in eye care
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
Subscribe To Our Newsletter & Stay Updated